Yüklüyor......
Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia
BACKGROUND: The pathophysiology of schizophrenia, a major psychiatric disorder, remains elusive. In this study, the role of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor (RXR) families, belonging to the ligand-activated nuclear receptor superfamily, in schizophrenia, was anal...
Kaydedildi:
| Yayımlandı: | EBioMedicine |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7728824/ https://ncbi.nlm.nih.gov/pubmed/33279456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2020.103130 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|